Shanler Stuart

CIK 00016543321 companyMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001654332

Recent Transactions

28 trades

Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2019-03-01+82,200→ 82,200 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-02-01+3,875→ 273,355 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-02-01−3,875→ 11,625 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-02-01$6.96/sh−1,308→ 272,047 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-12-18−1,450→ 1,450 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-18+1,450→ 269,892 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-18$6.30/sh−412→ 269,480 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-12-15−1,300→ 2,600 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-15$7.31/sh−370→ 268,442 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-15+1,300→ 268,812 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-05-07$18.10/sh−1,480→ 267,512 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-05-07+5,200→ 268,992 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-05-07−5,200→ 3,900 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2018-02-01+15,500→ 15,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2018-02-01+54,000→ 54,000 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-18$24.12/sh−441→ 263,792 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-18+1,450→ 264,233 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2017-12-18−1,450→ 2,900 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2017-12-15−1,300→ 9,100 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-15$24.23/sh−395→ 262,783 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-15+1,300→ 263,178 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-12-18$31.25/sh−441→ 261,878 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2016-12-18−1,450→ 4,350 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-12-18+1,450→ 262,319 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2016-12-15+10,400→ 10,400 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2016-12-15+62,400→ 62,400 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2015-12-18+5,800→ 5,800 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2015-12-18+53,833→ 53,833 total

Companies

Aclaris Therapeutics, Inc.
Chief Scientific Officer
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400

MALVERN, PA, 19355

View on SEC.gov